The Humble Organization
This post was written following the September 28, 2017 iJOBS event with Regeneron Regeneron prides itself for being a company thriving on quality research and the active role it plays in the entire life cycle of its drugs. The company was found by two M.D Ph.Ds (Leonard S. Schleifer and George D. Yancopoulos) with the goal of creating regenerative medicine for neuroscience research. The company, which initially received $1 million in venture capital funding, now has over 5,500 employees and 6 FDA-approved drugs, which were all invented in-house, from start to finish.


This past academic year, I was selected as a Raimondo Fellow as part of the Eagleton Fellowship program. This fellowship allows selected students to gain a better understanding of government, public affairs, and the legislative process through a class offered in the fall and an internship completed in the spring.